Chemical
Browse
Active Pharmaceutical Ingredients
Bioactive chemicals
Agrochemicals
Search
Chemical Structure
Explore
Chemical Similarity
Transformation
Browse
Prodrugs
Drug Metabolites
Metabolite Datasets
Cytochrome P450
Homo sapiens »
CYP1
CYP2
CYP3
CYP4
CYP5
CYP7
CYP8
CYP11
CYP17
CYP19
CYP20
CYP21
CYP24
CYP26
CYP27
CYP39
CYP46
CYP51
Mus musculus
Danio rerio
Oncorhynchus mykiss
Comparison of CYPs
Biochemical Action
Browse
Target Level (ChEMBL)
Level 1
Level 2
Level 3
Level 4
Level 5
Level 6
Mechanism of action
Search
Mechanism of action
BLAST against human drug target
BLAST against selected species (UniProt)
Exposure
Browse
Monitoring data
Downloads
Web services
Bulk downloads
About
About EcoDrug+
Citing
Data Sources
FAQ
Contact Us
Versions
Display Options:
Molecule Type
Mechanism of Action
Route of Adminstration
Status
Therapeutic Indication
Number of compounds:
220
TEMOZOLOMIDE
(1999)
Small molecule
DNA inhibitor
INTRAVENOUS; ORAL
Approved
Glioblastoma; Neoplasms
TEMOZOLOMIDE
×
Maximum Phase:
4
First Approval:
1999
UNII:
YF1K15M17Y
Molecule Type:
Small molecule
Molecular Formula:
C6H6N6O2
Molecular Weight:
194.15
AlogP:
-2.08
PSA:
108.17
HBD:
1.0
HBA:
#RotB:
1.0
Source:
OSELTAMIVIR PHOSPHATE
(1999)
Small molecule
Neuraminidase inhibitor
ORAL
Approved
Influenza, Human; Kidney Failure, Chronic
OSELTAMIVIR PHOSPHATE
×
Maximum Phase:
4
First Approval:
1999
UNII:
4A3O49NGEZ
Molecule Type:
Small molecule
Molecular Formula:
C16H31N2O8P
Molecular Weight:
410.4
AlogP:
1.29
PSA:
90.65
HBD:
2.0
HBA:
#RotB:
7.0
Source:
OSELTAMIVIR
(1999)
Small molecule
Unknown
Unknown
Approved
Virus Diseases
OSELTAMIVIR
×
Maximum Phase:
4
First Approval:
1999
UNII:
20O93L6F9H
Molecule Type:
Small molecule
Molecular Formula:
C16H28N2O4
Molecular Weight:
312.41
AlogP:
1.29
PSA:
90.65
HBD:
2.0
HBA:
#RotB:
7.0
Source:
UNOPROSTONE ISOPROPYL
(2000)
Small molecule
Unknown
OPHTHALMIC
Approved
Glaucoma
UNOPROSTONE ISOPROPYL
×
Maximum Phase:
4
First Approval:
2000
UNII:
5M161S5O5P
Molecule Type:
Small molecule
Molecular Formula:
C25H44O5
Molecular Weight:
424.62
AlogP:
5.12
PSA:
83.83
HBD:
2.0
HBA:
#RotB:
16.0
Source:
BALSALAZIDE DISODIUM
(2000)
Small molecule
Arachidonate 5-lipoxygenase inhibitor
ORAL
Approved
Colitis, Ulcerative
BALSALAZIDE DISODIUM
×
Maximum Phase:
4
First Approval:
2000
UNII:
1XL6BJI034
Molecule Type:
Small molecule
Molecular Formula:
C17H13N3Na2O6
Molecular Weight:
401.29
AlogP:
2.71
PSA:
148.65
HBD:
4.0
HBA:
#RotB:
7.0
Source:
BALSALAZIDE
(2000)
Small molecule
Unknown
Unknown
Approved
Unknown
BALSALAZIDE
×
Maximum Phase:
4
First Approval:
2000
UNII:
P80AL8J7ZP
Molecule Type:
Small molecule
Molecular Formula:
C17H15N3O6
Molecular Weight:
357.32
AlogP:
2.71
PSA:
148.65
HBD:
4.0
HBA:
#RotB:
7.0
Source:
OXCARBAZEPINE
(2000)
Small molecule
Sodium channel alpha subunit blocker
ORAL
Approved
Epilepsy; Seizures
OXCARBAZEPINE
×
Maximum Phase:
4
First Approval:
2000
UNII:
VZI5B1W380
Molecule Type:
Small molecule
Molecular Formula:
C15H12N2O2
Molecular Weight:
252.27
AlogP:
2.64
PSA:
63.4
HBD:
1.0
HBA:
#RotB:
0.0
Source:
ESOMEPRAZOLE
(2001)
Small molecule
Unknown
Unknown
Approved
Gastroesophageal Reflux; Peptic Ulcer
ESOMEPRAZOLE
×
Maximum Phase:
4
First Approval:
2001
UNII:
N3PA6559FT
Molecule Type:
Small molecule
Molecular Formula:
C17H19N3O3S
Molecular Weight:
345.42
AlogP:
2.9
PSA:
77.1
HBD:
1.0
HBA:
#RotB:
5.0
Source:
TOCOPHEROL ACETATE
(2001)
Small molecule
Unknown
Unknown
Approved
Unknown
TOCOPHEROL ACETATE
×
Maximum Phase:
4
First Approval:
2001
UNII:
9E8X80D2L0
Molecule Type:
Small molecule
Molecular Formula:
C31H52O3
Molecular Weight:
472.75
AlogP:
9.06
PSA:
35.53
HBD:
0.0
HBA:
#RotB:
13.0
Source:
TRAVOPROST
(2001)
Small molecule
Prostanoid FP receptor agonist
OPHTHALMIC
Approved
Glaucoma; Glaucoma, Open-Angle; Ocular Hypertension
TRAVOPROST
×
Maximum Phase:
4
First Approval:
2001
UNII:
WJ68R08KX9
Molecule Type:
Small molecule
Molecular Formula:
C26H35F3O6
Molecular Weight:
500.55
AlogP:
4.43
PSA:
96.22
HBD:
3.0
HBA:
#RotB:
12.0
Source:
ESOMEPRAZOLE MAGNESIUM
(2001)
Small molecule
Potassium-transporting ATPase inhibitor
ORAL
Approved
Arthritis, Rheumatoid; Duodenal Ulcer; Esophagitis; Gastroesophageal Reflux; Osteoarthritis; Spondylitis, Ankylosing; Stomach Ulcer; Zollinger-Ellison Syndrome
ESOMEPRAZOLE MAGNESIUM
×
Maximum Phase:
4
First Approval:
2001
UNII:
R6DXU4WAY9
Molecule Type:
Small molecule
Molecular Formula:
C34H36MgN6O6S2
Molecular Weight:
713.14
AlogP:
2.9
PSA:
77.1
HBD:
1.0
HBA:
#RotB:
5.0
Source:
VALGANCICLOVIR HYDROCHLORIDE
(2001)
Small molecule
Human herpesvirus 1 DNA polymerase inhibitor
ORAL
Approved
Acquired Immunodeficiency Syndrome; Cytomegalovirus Retinitis; Retinitis
VALGANCICLOVIR HYDROCHLORIDE
×
Maximum Phase:
4
First Approval:
2001
UNII:
4P3T9QF9NZ
Molecule Type:
Small molecule
Molecular Formula:
C14H23ClN6O5
Molecular Weight:
390.83
AlogP:
-1.44
PSA:
171.37
HBD:
4.0
HBA:
#RotB:
8.0
Source:
TENOFOVIR DISOPROXIL
(2001)
Small molecule
Unknown
Unknown
Approved
Virus Diseases
TENOFOVIR DISOPROXIL
×
Maximum Phase:
4
First Approval:
2001
UNII:
F4YU4LON7I
Molecule Type:
Small molecule
Molecular Formula:
C19H30N5O10P
Molecular Weight:
519.45
AlogP:
3.04
PSA:
185.44
HBD:
1.0
HBA:
#RotB:
13.0
Source:
VALGANCICLOVIR
(2001)
Small molecule
Unknown
Unknown
Approved
Virus Diseases
VALGANCICLOVIR
×
Maximum Phase:
4
First Approval:
2001
UNII:
GCU97FKN3R
Molecule Type:
Small molecule
Molecular Formula:
C14H22N6O5
Molecular Weight:
354.37
AlogP:
-1.44
PSA:
171.37
HBD:
4.0
HBA:
#RotB:
8.0
Source:
TENOFOVIR DISOPROXIL FUMARATE
(2001)
Small molecule
Human immunodeficiency virus type 1 reverse transcriptase inhibitor
ORAL
Approved
HIV Infections; Hepatitis B, Chronic; Infections; Liver Diseases
TENOFOVIR DISOPROXIL FUMARATE
×
Maximum Phase:
4
First Approval:
2001
UNII:
OTT9J7900I
Molecule Type:
Small molecule
Molecular Formula:
C23H34N5O14P
Molecular Weight:
635.52
AlogP:
3.04
PSA:
185.44
HBD:
1.0
HBA:
#RotB:
13.0
Source:
CEFDITOREN PIVOXIL
(2001)
Small molecule
Bacterial penicillin-binding protein inhibitor
ORAL
Approved
Bronchitis, Chronic; Infections; Pharyngitis; Tonsillitis
CEFDITOREN PIVOXIL
×
Maximum Phase:
4
First Approval:
2001
UNII:
78THA212DH
Molecule Type:
Small molecule
Molecular Formula:
C25H28N6O7S3
Molecular Weight:
620.74
AlogP:
2.3
PSA:
175.4
HBD:
2.0
HBA:
#RotB:
9.0
Source:
ADEFOVIR DIPIVOXIL
(2002)
Small molecule
DNA polymerase/reverse transcriptase inhibitor
ORAL
Approved
Hepatitis B, Chronic; Virus Diseases
ADEFOVIR DIPIVOXIL
×
Maximum Phase:
4
First Approval:
2002
UNII:
U6Q8Z01514
Molecule Type:
Small molecule
Molecular Formula:
C20H32N5O8P
Molecular Weight:
501.48
AlogP:
2.7
PSA:
166.98
HBD:
1.0
HBA:
#RotB:
11.0
Source:
NITAZOXANIDE
(2002)
Small molecule
Pyruvate:ferredoxin oxidoreductase inhibitor
ORAL
Approved
Diarrhea
NITAZOXANIDE
×
Maximum Phase:
4
First Approval:
2002
UNII:
SOA12P041N
Molecule Type:
Small molecule
Molecular Formula:
C12H9N3O5S
Molecular Weight:
307.29
AlogP:
2.23
PSA:
111.43
HBD:
1.0
HBA:
#RotB:
4.0
Source:
ESTRADIOL ACETATE
(2003)
Small molecule
Estrogen receptor alpha agonist
ORAL; VAGINAL
Approved
Atrophy; Menopause
ESTRADIOL ACETATE
×
Maximum Phase:
4
First Approval:
2003
UNII:
5R97F5H93P
Molecule Type:
Small molecule
Molecular Formula:
C20H26O3
Molecular Weight:
314.43
AlogP:
3.83
PSA:
46.53
HBD:
1.0
HBA:
#RotB:
1.0
Source:
FOSAMPRENAVIR
(2003)
Small molecule
Unknown
Unknown
Approved
Virus Diseases
FOSAMPRENAVIR
×
Maximum Phase:
4
First Approval:
2003
UNII:
WOU1621EEG
Molecule Type:
Small molecule
Molecular Formula:
C25H36N3O9PS
Molecular Weight:
585.62
AlogP:
2.52
PSA:
177.72
HBD:
4.0
HBA:
#RotB:
13.0
Source:
FOSAMPRENAVIR CALCIUM
(2003)
Small molecule
Human immunodeficiency virus type 1 protease inhibitor
ORAL
Approved
Autoimmune Diseases; HIV Infections
FOSAMPRENAVIR CALCIUM
×
Maximum Phase:
4
First Approval:
2003
UNII:
ID1GU2627N
Molecule Type:
Small molecule
Molecular Formula:
C25H34CaN3O9PS
Molecular Weight:
623.68
AlogP:
2.52
PSA:
177.72
HBD:
4.0
HBA:
#RotB:
13.0
Source:
EMTRICITABINE
(2003)
Small molecule
Human immunodeficiency virus type 1 reverse transcriptase inhibitor
ORAL
Approved
HIV Infections; Virus Diseases
EMTRICITABINE
×
Maximum Phase:
4
First Approval:
2003
UNII:
G70B4ETF4S
Molecule Type:
Small molecule
Molecular Formula:
C8H10FN3O3S
Molecular Weight:
247.25
AlogP:
-0.46
PSA:
90.37
HBD:
2.0
HBA:
#RotB:
2.0
Source:
TINIDAZOLE
(2004)
Small molecule
DNA inhibitor
ORAL
Approved
Amebiasis; Bacterial Infections; Trichomonas Infections; Vaginal Diseases; Vaginosis, Bacterial
TINIDAZOLE
×
Maximum Phase:
4
First Approval:
2004
UNII:
033KF7V46H
Molecule Type:
Small molecule
Molecular Formula:
C8H13N3O4S
Molecular Weight:
247.28
AlogP:
0.53
PSA:
95.1
HBD:
0.0
HBA:
#RotB:
5.0
Source:
OMEGA-3-ACID ETHYL ESTERS
(2004)
Small molecule
Unknown
ORAL
Approved
Cardiovascular Diseases; Diabetes Mellitus; Diabetes Mellitus, Type 2; Hypothyroidism
OMEGA-3-ACID ETHYL ESTERS
×
Maximum Phase:
4
First Approval:
2004
UNII:
D87YGH4Z0Q
Molecule Type:
Small molecule
Molecular Formula:
C46H70O4
Molecular Weight:
687.06
AlogP:
None
PSA:
None
HBD:
None
HBA:
#RotB:
None
Source:
CLOFARABINE
(2004)
Small molecule
DNA inhibitor
INJECTION; INTRAVENOUS
Approved
Neoplasms; Precursor Cell Lymphoblastic Leukemia-Lymphoma
CLOFARABINE
×
Maximum Phase:
4
First Approval:
2004
UNII:
762RDY0Y2H
Molecule Type:
Small molecule
Molecular Formula:
C10H11ClFN5O3
Molecular Weight:
303.68
AlogP:
-0.35
PSA:
119.31
HBD:
3.0
HBA:
#RotB:
2.0
Source:
METHYL AMINOLEVULINATE
(2004)
Small molecule
Unknown
Unknown
Approved
Neoplasms
METHYL AMINOLEVULINATE
×
Maximum Phase:
4
First Approval:
2004
UNII:
585NM85KYM
Molecule Type:
Small molecule
Molecular Formula:
C6H11NO3
Molecular Weight:
145.16
AlogP:
-0.53
PSA:
69.39
HBD:
1.0
HBA:
#RotB:
4.0
Source:
METHYL AMINOLEVULINATE HYDROCHLORIDE
(2004)
Small molecule
DNA inhibitor
TOPICAL
Approved
Glioma
METHYL AMINOLEVULINATE HYDROCHLORIDE
×
Maximum Phase:
4
First Approval:
2004
UNII:
7S73606O1A
Molecule Type:
Small molecule
Molecular Formula:
C6H12ClNO3
Molecular Weight:
181.62
AlogP:
-0.53
PSA:
69.39
HBD:
1.0
HBA:
#RotB:
4.0
Source:
AZACITIDINE
(2004)
Small molecule
DNA (cytosine-5)-methyltransferase 1 inhibitor
INTRAVENOUS; SUBCUTANEOUS
Approved
Anemia; Anemia, Refractory, with Excess of Blasts; Leukemia, Myelomonocytic, Chronic; Myelodysplastic Syndromes; Neoplasms; Thrombocytopenia
AZACITIDINE
×
Maximum Phase:
4
First Approval:
2004
UNII:
M801H13NRU
Molecule Type:
Small molecule
Molecular Formula:
C8H12N4O5
Molecular Weight:
244.21
AlogP:
-3.17
PSA:
143.72
HBD:
4.0
HBA:
#RotB:
2.0
Source:
ESOMEPRAZOLE SODIUM
(2005)
Small molecule
Potassium-transporting ATPase inhibitor
INTRAVENOUS
Approved
Duodenal Ulcer; Gastroesophageal Reflux
ESOMEPRAZOLE SODIUM
×
Maximum Phase:
4
First Approval:
2005
UNII:
L2C9GWQ43H
Molecule Type:
Small molecule
Molecular Formula:
C17H18N3NaO3S
Molecular Weight:
367.41
AlogP:
2.9
PSA:
77.1
HBD:
1.0
HBA:
#RotB:
5.0
Source:
NEPAFENAC
(2005)
Small molecule
Cyclooxygenase inhibitor
OPHTHALMIC
Approved
Cataract; Eye Diseases; Inflammation
NEPAFENAC
×
Maximum Phase:
4
First Approval:
2005
UNII:
0J9L7J6V8C
Molecule Type:
Small molecule
Molecular Formula:
C15H14N2O2
Molecular Weight:
254.29
AlogP:
1.53
PSA:
86.18
HBD:
2.0
HBA:
#RotB:
4.0
Source:
NELARABINE
(2005)
Small molecule
DNA inhibitor
INTRAVENOUS
Approved
Leukemia-Lymphoma, Adult T-Cell; Neoplasms
NELARABINE
×
Maximum Phase:
4
First Approval:
2005
UNII:
60158CV180
Molecule Type:
Small molecule
Molecular Formula:
C11H15N5O5
Molecular Weight:
297.27
AlogP:
-1.97
PSA:
148.77
HBD:
4.0
HBA:
#RotB:
3.0
Source:
ENTECAVIR
(2005)
Small molecule
DNA polymerase/reverse transcriptase inhibitor
ORAL
Approved
Hepatitis B; Hepatitis B, Chronic; Liver Diseases; Virus Diseases
ENTECAVIR
×
Maximum Phase:
4
First Approval:
2005
UNII:
5968Y6H45M
Molecule Type:
Small molecule
Molecular Formula:
C12H15N5O3
Molecular Weight:
277.28
AlogP:
-0.83
PSA:
130.05
HBD:
4.0
HBA:
#RotB:
2.0
Source:
DECITABINE
(2006)
Small molecule
DNA (cytosine-5)-methyltransferase 1 inhibitor
INTRAVENOUS
Approved
Anemia; Anemia, Refractory, with Excess of Blasts; Leukemia, Myelomonocytic, Chronic; Myelodysplastic Syndromes; Neoplasms
DECITABINE
×
Maximum Phase:
4
First Approval:
2006
UNII:
776B62CQ27
Molecule Type:
Small molecule
Molecular Formula:
C8H12N4O4
Molecular Weight:
228.21
AlogP:
-2.14
PSA:
123.49
HBD:
3.0
HBA:
#RotB:
2.0
Source:
CICLESONIDE
(2006)
Small molecule
Glucocorticoid receptor agonist
INHALATION; NASAL
Approved
Asthma; Lung Diseases, Obstructive; Nasal Obstruction; Rhinitis, Allergic, Perennial; Rhinitis, Allergic, Seasonal
CICLESONIDE
×
Maximum Phase:
4
First Approval:
2006
UNII:
S59502J185
Molecule Type:
Small molecule
Molecular Formula:
C32H44O7
Molecular Weight:
540.7
AlogP:
4.7
PSA:
99.13
HBD:
1.0
HBA:
#RotB:
5.0
Source:
LISDEXAMFETAMINE DIMESYLATE
(2007)
Small molecule
Dopamine transporter releasing agent
ORAL
Approved
Arteriosclerosis; Attention Deficit Disorder with Hyperactivity; Binge-Eating Disorder; Glaucoma; Substance-Related Disorders
LISDEXAMFETAMINE DIMESYLATE
×
Maximum Phase:
4
First Approval:
2007
UNII:
SJT761GEGS
Molecule Type:
Small molecule
Molecular Formula:
C17H33N3O7S2
Molecular Weight:
455.6
AlogP:
1.19
PSA:
81.14
HBD:
3.0
HBA:
#RotB:
8.0
Source:
LISDEXAMFETAMINE
(2007)
Small molecule
Unknown
Unknown
Approved
Attention Deficit Disorder with Hyperactivity
LISDEXAMFETAMINE
×
Maximum Phase:
4
First Approval:
2007
UNII:
H645GUL8KJ
Molecule Type:
Small molecule
Molecular Formula:
C15H25N3O
Molecular Weight:
263.38
AlogP:
1.19
PSA:
81.14
HBD:
3.0
HBA:
#RotB:
8.0
Source:
1
2
3
4
5
6
7
Next »
Download Option
Close
Header
Compound Name
Maximum Phase
Compound Structure
Smile
Inchi
InchiKey
Compound Properties
Molecular Formula
Molecular Weight
ALogP
PSA